A Combination of Two Receptor Tyrosine Kinase Inhibitors, Canertinib and PHA665752 Compromises Ovarian Cancer Cell Growth in 3D Cell Models

Journal article

Open access

Peer reviewed

Wafaa Hassan, Kenny Chitcholtan, Peter Sykes and Ashley Garrill

Oncology and therapy, Vol.4(2), pp.257-274

01/12/2016

Handle:

https://hdl.handle.net/10523/28959

Abstract

Original Research

url

https://doi.org/10.1007/s40487-016-0031-1View

Published (Version of record) Open

9 Record Views

Record Identifier: 9926515315901891
Title: A Combination of Two Receptor Tyrosine Kinase Inhibitors, Canertinib and PHA665752 Compromises Ovarian Cancer Cell Growth in 3D Cell Models
Creators: Wafaa Hassan
Kenny Chitcholtan
Peter Sykes
Ashley Garrill
Publication Details: Oncology and therapy, Vol.4(2), pp.257-274
Academic Unit: Obstetrics and Gynaecology (UOC)
Publisher: Springer Healthcare
Date published ; e-published: 01/12/2016
Language: English
Resource Type ; Subtype: Journal article